Emami (531162) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
8 Jul, 2026Executive summary
Core domestic business grew by 11% in Q4 FY25, with 7% volume growth, and international business rebounded with 6% growth in Q4 despite challenges.
Strategic investments in The Man Company and Brillare are targeted for high double-digit growth in FY26.
Over 25 new products launched in FY25, with digital-first Zandu Care portfolio growing over 50% year-on-year.
Audited standalone and consolidated financial results for FY25 were approved, with auditors issuing an unmodified opinion.
Special dividend of 200% (Rs. 2 per share) declared as the 3rd interim dividend for FY25, celebrating 50 years.
Financial highlights
Q4 consolidated revenue rose 8% year-over-year to INR 963 crore; gross margin expanded 10 bps to 65.9%.
FY25 consolidated revenue grew 6.5% to INR 3,809 crore; gross margin up 100 bps to 68.6%.
Q4 EBITDA grew 4% to INR 219 crore; profit after tax up 14% to INR 194 crore.
FY25 EBITDA up 8% to INR 1,025 crore; EBITDA margin improved 40 bps to 26.9%.
Consolidated PAT for FY25 stood at Rs. 80,274 lacs, compared to Rs. 72,414 lacs in FY24.
Outlook and guidance
Optimism for strong performance in FY26, with positive momentum expected in male grooming, Kskin, and The Man Company.
Anticipates gradual consumption pickup, aided by easing inflation, tax benefits, higher government CapEx, and potential rate cuts.
Strategic focus on ramping up growth in subsidiaries, cost optimization, and omnichannel distribution.
Continued investment in new product launches and digital marketing to drive future growth.
One manufacturing facility in Assam continues to benefit from income tax incentives under section 80IE until FY26.
Latest events from Emami
- Q3 FY25 saw 8.6% core domestic growth, margin gains, and Rs 8/share interim dividends.531162
Q3 24/258 Jul 2026 - Revenue and profit rose double digits, led by strong brand growth and margin expansion.531162
Q1 24/258 Jul 2026 - Q2 delivered profit-led growth, margin expansion, and a ₹4/share dividend despite headwinds.531162
Q2 24/258 Jul 2026 - FY26 saw lower revenue and profit, but D2C and new-age brands showed strong growth.531162
Q4 25/2621 May 2026 - Double-digit sales and profit growth, margin gains, and interim dividend highlight strong Q3 FY26.531162
Q3 25/2613 Apr 2026 - Flat revenue, higher margins, and strong pain management offset summer category declines.531162
Q1 25/263 Feb 2026 - Q2 FY26 revenue fell 10% and profit dropped 29.7%, with a Rs. 4 interim dividend declared.531162
Q2 25/2610 Nov 2025